Literature DB >> 32949615

Analysis of PON1 gene polymorphisms (rs662 and rs854560) and inflammatory markers in organophosphate pesticides exposed cohorts from two distinct populations.

Mbah Ntepe Leonel Javeres1, Rabia Habib1, Ngondi Judith2, Moaz Iqbal1, Eugenie Nepovimova3, Kamil Kuca4, Sajida Batool1, Syed Muhammad Nurulain5.   

Abstract

BACKGROUND AND OBJECTIVES: Organophosphate (OPs) anticholinesterases are one of the main groups of pesticides used in agriculture. Harmful effects of OPs on health have been attributed primarily for irreversible inhibition of acetylcholinesterase (AChE) at nerve synapse. However, studies have shown that inhibition of AChE alone cannot explain all the maladies encountered in prolonged exposure to OPs. Predisposition to population heterogeneity and irregularities in various biochemicals like paraoxonases and inflammatory biochemicals are the possible affects of OPs long term exposure that may lead to sequels of diseases and are less addressed in literature. The study was aimed to assess the cholinergic enzymes (AChE and BChE), PON1, and inflammatory markers (IL1β, IL6, TNFα, CRP, Apo AI, Apo B) and determine the toxicogenetics association of PON1 gene (rs 662 and rs 85456) to chronically OPs exposed groups from Pakistan and Cameroon.
MATERIALS AND METHODS: AChE, BChE and PON1 were measured by colorimetric method using spectrophotometry. Inflammatory markers were determined by Elisa assay. PCR-restriction fragment length polymorphism (PCR-RFLP) using salting out method was employed for SNP genotyping.
RESULTS: The results revealed the significant (p ≤ 0.05) inhibition of cholinergic enzymes PON 1 was found to be 6.91 ng/mL±1.03 and 2.84 ng/mL±1.40 (mean ± SD) in Pakistan and Cameroon groups respectively. IL6, TNFα, CRP were increased and Apo AI was less while Apo B was increased in OP exposed groups in both population groups. SNPs analysis of PON1 showed significant differences in allelic and genotype frequencies of OPs exposed and non-exposed groups.
CONCLUSIONS: PON1 was noticeably less in Cameroonian than Pakistani, albeit both groups have significant decrease in PON1 actity. In addition, the study concludes that OPs induce low grade inflammation, an aetiology of many diseases. Selected PON1 SNPs analysis showed a significant toxicogenetics association with OPs exposure marker enzymes. The results of this study may help in regulation of usage of OPs anticholinesterases in different populations. The study will further open new avenues in toxicogenetic and exploration of SNPs based strategies on organophosphate intoxication.
Copyright © 2020 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Apolipoprotein; Cholinergic enzymes; Cytokines; Organophosphates; PON1,toxicogenetic

Year:  2020        PMID: 32949615     DOI: 10.1016/j.envres.2020.110210

Source DB:  PubMed          Journal:  Environ Res        ISSN: 0013-9351            Impact factor:   6.498


  4 in total

Review 1.  Co-Players in Chronic Pain: Neuroinflammation and the Tryptophan-Kynurenine Metabolic Pathway.

Authors:  Masaru Tanaka; Nóra Török; Fanni Tóth; Ágnes Szabó; László Vécsei
Journal:  Biomedicines       Date:  2021-07-26

2.  Insights of OPs and PYR cytotoxic potential Invitro and genotoxic impact on PON1 genetic variant among exposed workers in Pakistan.

Authors:  Iffat Imran; Asma Ansari; Saima Saleem; Abid Azhar; Sitwat Zehra
Journal:  Sci Rep       Date:  2022-06-09       Impact factor: 4.996

3.  Chronic Exposure to Organophosphates Pesticides and Risk of Metabolic Disorder in Cohort from Pakistan and Cameroon.

Authors:  Mbah Ntepe Leonel Javeres; Rabia Habib; Ngondi Judith Laure; Syed Tahir Abbas Shah; Martin Valis; Kamil Kuca; Syed Muhammad Nurulain
Journal:  Int J Environ Res Public Health       Date:  2021-02-26       Impact factor: 3.390

4.  Association between human paraoxonase 2 protein and efficacy of acetylcholinesterase inhibiting drugs used against Alzheimer's disease.

Authors:  Fauzia Parween; Md Summon Hossain; Kshetra Pal Singh; Rinkoo Devi Gupta
Journal:  PLoS One       Date:  2021-10-29       Impact factor: 3.240

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.